Trials / Recruiting
RecruitingNCT05113017
The Effectiveness and Safety of SBRT in the Treatment of Patients With MPLC After Surgery (SMILE)
To Evaluate the Effectiveness and Safety of Stereotactic Radiotherapy (SBRT) in the Treatment of Patients With Residual Malignant Pulmonary Nodules After Lung Cancer Surgery: A Multi-center, Prospective Clinical Trial (SMILE)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (estimated)
- Sponsor
- Fang Wu · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To prospectively evaluate the effectiveness and safety of SBRT in the treatment of residual malignant pulmonary nodules after lung cancer, and is committed to providing new treatment options for patients with multiple primary malignant pulmonary nodules who cannot tolerate multiple operations.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | NO Intervention | NO Intervention |
Timeline
- Start date
- 2021-07-01
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
- First posted
- 2021-11-09
- Last updated
- 2025-11-28
Locations
5 sites across 1 country: China
Source: ClinicalTrials.gov record NCT05113017. Inclusion in this directory is not an endorsement.